Riskpilot← Back to searchSign inGet full accessONCONOX ApS
APSBankruptCVR 33858965Kastanievej 25Research and experimental development on natural sciences and engineering · NACE 7210Est. 2011— employees
Revenue 2022
—
EBITDA margin
—
+7% vs 2021
Equity ratio
-20.0%
Financial strength
Net profit 2022
DKK -41K
+7% vs 2021
| Revenue | — | — |
| EBITDA | DKK -38K | +7% |
| Net profit | DKK -41K | +7% |
| Total assets | DKK 21K | -5% |
| Equity | DKK -4K | +90% |
| Employees | — | — |
Legal name
ONCONOX ApS
CVR number
33858965
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4. juli 2011
Share capital
DKK 98.300
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at drive forretning med farmaceutisk udvikling og dermed beslægtet virksomhed
Address
Kastanievej 25
Phone
+4553635085
Email
bdh@zolved.dk
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -705 | — | — | — | 0 | 547 | 0 | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -37 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -831 | -193 | -50 | 1.467 | -37 | 513 | -55 | -61 | -9 | -41 | -38 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -831 | -193 | -50 | 1.467 | -37 | 513 | -55 | -61 | -9 | -41 | -38 |
| Net financials | -0 | 2 | 0 | -17 | -4 | -8 | -975 | -5 | -4 | -3 | -3 |
| Profit before tax | -831 | -191 | -50 | 1.450 | -41 | 506 | -1.029 | -66 | -13 | -44 | -41 |
| Tax | -119 | -0 | -0 | -0 | -26 | 113 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -712 | -191 | -50 | 1.450 | -15 | 393 | -1.029 | -66 | -13 | -44 | -41 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 326 | 127 | 10 | 1.040 | 1.015 | 1.168 | 61 | 47 | 55 | 23 | 21 |
| Equity | 240 | 50 | -0 | 1.010 | 995 | 1.059 | 29 | -37 | 1 | -43 | -4 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 85 | 77 | 10 | 30 | 19 | 109 | 32 | 84 | 55 | 66 | 26 |
| Total debt | 85 | 77 | 10 | 30 | 19 | 109 | 32 | 84 | 55 | 66 | 26 |
EBITDA margin
-3756600.0%
This company
15.8%
Market median
-23776049% vs market
20122022
Equity ratio
-20.0%
This company
38.2%
Market median
-152% vs market
20122022
Return on equity
-4067200.0%
This company
18.4%
Market median
-22104448% vs market
20122022
Net profit margin
-4067200.0%
This company
8.1%
Market median
-50212446% vs market
20122022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122022
Debt / equity
5.99×
This company
0.62×
Market median
-866% vs market
20122022
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JS Founder | Founder | 2011 | — | — |
BD Management | Management | 2020 | — | — |
OK Unofficial title | Unofficial title | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 2013 | — | — | |
| Chairman | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2019 | |
| Individual | 20.0% | 20.0% | 2018 | |
| Individual | 20.0% | 20.0% | 2013 | |
| Individual | 20.0% | 20.0% | 2011 | |
| Individual | 20.0% | 20.0% | 2011 | |
| Individual | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ONCONOX ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Smedegaard Madsen | Founder | 0 companies |
| Bo Danner Henriksen | Management | 0 companies |
| Ole Kjær | Unofficial title | 0 companies |
| Frank Knudsen | Board of Directors | 0 companies |
| Ole Bitsch-Jensen | Board of Directors | 0 companies |
| Hans Thalsgård Schambye | Chairman | 0 companies |
| Gianni Garotta | Chairman | 0 companies |
| Ferdinando Nicoletti | Chairman | 0 companies |